A skin cancer diagnosis can feel overwhelming — but surgery isn't your only option. At Hudson Dermatology, Dr. Neera Agarwal-Antal offers GentleCure, an FDA-cleared, non-surgical skin cancer treatment that delivers a 99%+ cure rate without a single incision. Powered by Image-Guided Superficial Radiation Therapy (IG-SRT), GentleCure uses precisely targeted, low-dose X-ray energy to destroy basal cell carcinoma and squamous cell carcinoma cells while leaving healthy surrounding tissue unharmed. There's no cutting, no anesthesia, no scarring, and no downtime — just effective, gentle skin cancer treatment delivered right here in our Hudson, Ohio office.
As a board-certified dermatologist with four medical board certifications, Dr. Agarwal-Antal is uniquely qualified to evaluate your diagnosis and guide you toward the treatment that's right for your specific case.
If you're looking for GentleCure near you or exploring alternatives to Mohs surgery, Hudson Dermatology is here to help. Request an appointment today to discuss your options.
GentleCure is the brand name for Image-Guided Superficial Radiation Therapy (IG-SRT) — a cutting-edge form of radiation therapy for skin cancer performed entirely in a dermatologist's office. Unlike traditional radiation used for internal cancers, IG-SRT uses low levels of X-ray energy — similar to what a dentist uses for dental X-rays — to target and destroy non-melanoma skin cancer cells near the surface of the skin. What sets GentleCure apart from other radiation therapy for skin cancer is its use of real-time ultrasound imaging. At the start of each session, an imaging wand visualizes the exact size and shape of the tumor on screen, allowing Dr. Agarwal-Antal to calculate the precise dose needed and define the exact treatment area before delivering the radiation. You can even see the images yourself from the comfort of your chair and watch the cancer shrink over the course of treatment.
Each GentleCure treatment session is straightforward and brief. You'll sit comfortably in a chair while ultrasound gel is applied to the treatment site. After imaging is complete, the device arm is positioned over the area and the targeted dose of X-ray energy is delivered in just minutes. Most sessions take about 10–15 minutes from arrival to departure. Treatment is typically completed over four to seven weeks with several short sessions per week. There is no recovery period, no wound care, and no restrictions on daily activities between visits.
When it comes to basal cell carcinoma treatment and squamous cell carcinoma, patients are often told that Mohs surgery is their only option — but GentleCure offers a clinically proven alternative. Research involving more than 2,900 early-stage skin cancers found that IG-SRT achieves a 99.3% cure rate, comparable to Mohs surgery, and in a survey of more than 12,000 patients who completed GentleCure treatment, 99.9% said they were satisfied and would recommend it to others. GentleCure is particularly well-suited for patients who want to avoid surgery, those whose cancers are in areas where surgery could be disfiguring, patients on blood thinners or with medical conditions that make surgery risky, and older adults seeking a comfortable, low-impact treatment experience. GentleCure is covered by most major health insurance plans, and Dr. Agarwal-Antal's team can help verify your benefits before treatment begins.
GentleCure (IG-SRT treatment) is designed to treat non-melanoma skin cancers, including basal cell carcinoma and squamous cell carcinoma. It is most effective for early-stage cancers and those located on or near the surface of the skin. During your consultation at Hudson Dermatology, Dr. Agarwal-Antal will review your pathology report and help determine whether GentleCure is the right approach for your specific diagnosis.
Yes. GentleCure is FDA-cleared and has been used to treat tens of thousands of patients. The X-ray energy used in IG-SRT penetrates only a few millimeters into tissue and has little effect on surrounding healthy skin or underlying structures. In the years that patients have been receiving GentleCure, there have been no reported cases of secondary skin cancers resulting from treatment. The most common side effects are mild and temporary, including minor redness or irritation at the treatment site, which typically resolves within a few weeks of completing treatment.
Not all radiation therapy for skin cancer is the same. GentleCure is the only skin cancer radiation treatment that uses ultrasound imaging to visualize the tumor at every session, allowing for adaptive dosing that is tailored to the size and shape of the cancer as it changes throughout treatment. This precision sets it apart from older, non-image-guided forms of radiation therapy and results in superior cosmetic outcomes and safety.
Hudson Dermatology makes it easy to access GentleCure right here in Hudson, Ohio — no need to travel to a hospital or specialty center. Dr. Agarwal-Antal and her team offer online scheduling and are happy to see new patients promptly. If you've recently been diagnosed with skin cancer or are exploring non-surgical skin cancer treatment options, we look forward to meeting you and helping you find the path forward that's right for you. Request an appointment today.